In the News August 25, 2020

Pink Sheet | What the FDA’s Inspections Q&A Guidance Really Means: It’s Time to Offer Virtual Inspections

Cathy Burgess is quoted on recent guidance by the U.S. Food and Drug Administration that could include virtual inspections of manufacturing sites amid COVID-19 and how the industry should continue urging the FDA to adopt these new approaches.
Media Contact
Alex Wolfe
Communications Director
Phone: 212.210.9442

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.